Oxygen therapy for preterm neonates: The elusive optimal target

JAMA Pediatrics

Volumn 169, Issue 4, 2015, Pages 311-313

  Synnes, Anne ^a   Miller, Steven P ^b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADVERSE OUTCOME; EDITORIAL; HUMAN; LUNG DISEASE; OXYGEN SATURATION; OXYGEN THERAPY; OXYGENATION; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME; BLOOD; STANDARDS;

HUMANS; OXYGEN; OXYGEN INHALATION THERAPY;

EID: 84928241097     PISSN: 21686203     EISSN: 21686211     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2014.3664     Document Type: Editorial

References (17)

1. Askie LM, Henderson-Smart DJ, Ko H. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2009; (1):CD001077
2. Higgins RD, Bancalari E,Willinger M, Raju TN. Executive summary of the workshop on oxygen in neonatal therapies: controversies and opportunities for research. Pediatrics. 2007;119(4): 790-796
3. SilvermanWA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics. 2004;113(2):394-396
4. TinW. Oxygen therapy: 50 years of uncertainty. Pediatrics. 2002;110(3):615-616
5. Saugstad OD, Aune D. Optimal oxygenation of extremely low birth weight infants: ameta-analysis and systematic review of the oxygen saturation target studies. Neonatology. 2014;105(1):55-63
6. Manja V, Lakshminrusimha S, Cook DJ. Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis [published online February 9, 2015]. JAMA Pediatr. doi:10.1001/jamapediatrics.2014.3307
7. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1, introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394
8. Schmidt B, Roberts RS,Whyte RK, et al; Canadian Oxygen Trial Group. Impact of study oximeter masking algorithm on titration of oxygen therapy in the Canadian oxygen trial. J Pediatr. 2014;165(4):666-671
9. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics. 2008;122(3):479-485
10. Wang H, St Julien KR, Stevenson DK, et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics. 2013;132 (2):290-297
11. Poggi C, Giusti B, Vestri A, Pasquini E, Abbate R, Dani C. Genetic polymorphisms of antioxidant enzymes in preterm infants. J Matern Fetal Neonatal Med. 2012;25(suppl 4):131-134
12. Lee SK, McMillan DD, Ohlsson A, et al. Variations in practice and outcomes in the Canadian NICU network: 1996-1997. Pediatrics. 2000;106 (5):1070-1079
13. 2 in the two groups? A subgroup analysis of the Canadian Oxygen Trial (COT). E-PAS2014:1400.5. http://www.abstracts2view.com/pas/view.php?nu=PAS14L1-1400.5. Accessed January 8, 2015
14. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial, I: primary outcomes. Pediatrics. 2000;105(2):295-310
15. Schmidt B, Davis PG, Asztalos EV, Solimano A, Roberts RS. Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years. JAMA. 2014;311(5):523-525
16. Seed M, Macgowan CK. Fetal cardiovascular MRI. MAGNETOM Flash. 2014;2(57):66-72.http://www.healthcare.siemens.com/siemens-hwem-hwem-ssxa-websites-context-root/wcm/idc/siemens-hwem-hwem-ssxa-websites-context-root/wcm/idc/groups/public/@global/@imaging/@mri/documents/download/mdaz/mdmz/~edisp/mri-57-seed-01390790.pdf. Accessed January 8, 2015
17. Lin PY, Roche-Labarbe N, DehaesM, Fenoglio A, Grant PE, Franceschini MA. Regional and hemispheric asymmetries of cerebral hemodynamic and oxygen metabolism in newborns. Cereb Cortex. 2013;23(2):339-348.